This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
MIT Technology Review Narrated
00:00
Limits of small trials and therapeutic misconception
Michael Guzmano stresses small studies can't prove longevity and may mislead participants.
Play episode from 10:26
Transcript
